Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 4, 2007

AstraZeneca Acquires Biologics Manufacturing Facility in Canada

  • AstraZeneca acquired a Montreal-based biologics manufacturing facility from DSM Biologics. The facility, occupying 66,000 sq. ft., will be used to manufacture antibody drug candidates for clinical trials and will serve the whole of the AstraZeneca group.

    Work to recommission the facility is expected to begin immediately, and the company plans to commence full scale production in 2009.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »